Publication | Closed Access

pH-responsive selenium nanoparticles stabilized by folate-chitosan delivering doxorubicin for overcoming drug-resistant cancer cells

NanomedicineEngineeringPolymer-drug ConjugatePh-responsive Selenium NanoparticlesNano-drug DeliveryTumor TargetingFolate-chitosan Delivering DoxorubicinRadiation OncologyBiomolecular EngineeringDrug-resistant Cancer Cells